Otros idiomas Samsung Biologics Co.,Ltd.

Acciones

A207940

KR7207940008

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
770.000 ^KRW	-1,28 %		-1,41 %	+1,32 %

25/04	Samsung Bioepis obtiene la aprobación para comercializar un tratamiento autoinmune en Europa	MT
25/04	Samsung Biologics obtiene mayores beneficios y ventas en el primer trimestre	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Samsung Biologics Reports First Quarter 2024 Financial Results	25/04
Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	25/04
Samsung Biologics Posts Higher Q1 Profit, Sales	25/04
Samsung Biologics Boosts Contract Size with MSD Switzerland	08/04
Samsung Life Science Fund Invests in BrickBio	20/03
Samsung Life Science Fund Invests in Biologics Developer	20/03
CEO IR Newsletter : 2024 AGM Wrap Up	15/03
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	15/03
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	12/03
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	07/03
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	07/03
Samsung Biologics signs MOU with Seoul National University to foster bio experts	01/03
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	29/02
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Samsung Biologics awarded Leadership status by CDP for climate action efforts	14/02
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	09/02
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	08/02
Samsung chair found not guilty of charges connected to 2015 merger	05/02
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger	05/02
Samsung chief acquitted in controversial 2015 merger case	05/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Samsung Biologics Co.,Ltd.

Acciones

A207940

KR7207940008

Otros idiomas

Filtros